Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03189186 |
| Title | Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | University of California, Irvine |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |